IRCT2016062328603N1已完成2 期
Study of the effectiveness of a combination of methadone treatment with group treatment based on Acceptance & Commitment therapy (ACT) versus methadone treatment in the prevention rate of relapse in people with abuse opioids.
Vice chancellor for research Zanjan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- Male
入选标准
- •Having informed consent to participate in research; Taking at least two weeks Methadone; Being male; Having a minimum of 18 & maximum of 45 years old. Exclusion criteria: Patient will be deleted after the two meeting absence; More severe problems, such as suicidal thoughts or have psychotic disorders
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
To evaluate the efficacy of two drugs methylprednisolone and etoricoxib in laproscopic surgeryCTRI/2019/03/018041Department of anaesthesiology Jln Medical College ajmer
招募中
1 期
This is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UVB TL01 in vitiligo.Vitiligo with new lesions or extension of old lesions during the last 6 monthsCTIS2024-512766-34-00Centre Hospitalier Universitaire De Bordeaux48
已完成
4 期
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.CTRI/2021/04/033194Bangalore Medical College and Research Institute70
进行中（未招募）
不适用
To evaluate the effectiveness of MetaDerm Cream in Atopic DermatitisCTRI/2017/06/008950Haus Bioceuticals Inc
已完成
不适用
A Phase II Randomised Study of the Addition of Methotrexate 0.05 mg/kg 12 hourly for 8 doses to the Current Immunosuppressant Regimen for the Prevention of Liver Allograft Rejection.ISRCTN58758525Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)60